Resmed (RMD) Receivables - Net (2016 - 2025)
Resmed (RMD) has disclosed Receivables - Net for 16 consecutive years, with $985.6 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Receivables - Net rose 14.62% year-over-year to $985.6 million, compared with a TTM value of $985.6 million through Dec 2025, up 14.62%, and an annual FY2025 reading of $939.5 million, up 12.21% over the prior year.
- Receivables - Net was $985.6 million for Q4 2025 at Resmed, up from $907.3 million in the prior quarter.
- Across five years, Receivables - Net topped out at $985.6 million in Q4 2025 and bottomed at $508.6 million in Q1 2022.
- Average Receivables - Net over 5 years is $723.0 million, with a median of $698.6 million recorded in 2023.
- The sharpest move saw Receivables - Net decreased 6.24% in 2022, then skyrocketed 34.94% in 2023.
- Year by year, Receivables - Net stood at $526.0 million in 2021, then rose by 27.8% to $672.3 million in 2022, then increased by 8.55% to $729.7 million in 2023, then rose by 17.84% to $859.9 million in 2024, then increased by 14.62% to $985.6 million in 2025.
- Business Quant data shows Receivables - Net for RMD at $985.6 million in Q4 2025, $907.3 million in Q3 2025, and $939.5 million in Q2 2025.